Grand Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG210A71016
HKD
5.49
0.03 (0.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
China Medical System Holdings Ltd.
WuXi AppTec Co., Ltd.
Simcere Pharmaceutical Group Ltd.
Grand Pharmaceutical Group Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
China Traditional Chinese Medicine Holdings Co. Ltd.
HUTCHMED (China) Ltd.
Akeso, Inc.

Why is Grand Pharmaceutical Group Ltd. ?

1
The company has declared Negative results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at HKD 3,224.69 MM
  • ROCE(HY) Lowest at 7.41%
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,036.74
2
With ROE of 10.19%, it has a Expensive valuation with a 1.49 Price to Book Value
  • Over the past year, while the stock has generated a return of -36.82%, its profits have fallen by -19.9%
3
Below par performance in long term as well as near term
  • Along with generating -36.82% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.34%
EBIT Growth (5y)
6.17%
EBIT to Interest (avg)
15.55
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.54
Tax Ratio
14.29%
Dividend Payout Ratio
47.69%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.40%
ROE (avg)
14.09%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.49
EV to EBIT
16.28
EV to EBITDA
12.42
EV to Capital Employed
1.42
EV to Sales
2.41
PEG Ratio
NA
Dividend Yield
3.62%
ROCE (Latest)
8.71%
ROE (Latest)
10.19%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 824.39%

INVENTORY TURNOVER RATIO(HY)

Highest at 3.86 times

NET SALES(Q)

Highest at HKD 6,175.95 MM

-13What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at HKD 3,224.69 MM

ROCE(HY)

Lowest at 7.41%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,036.74

RAW MATERIAL COST(Y)

Grown by 12.18% (YoY

OPERATING PROFIT(Q)

Lowest at HKD 850 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 13.76 %

PRE-TAX PROFIT(Q)

Lowest at HKD 491.98 MM

NET PROFIT(Q)

Lowest at HKD 220.51 MM

EPS(Q)

Lowest at HKD 0.02

Here's what is working for Grand Pharmaceutical Group Ltd.

Net Sales
Highest at HKD 6,175.95 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Inventory Turnover Ratio
Highest at 3.86 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Dividend Payout Ratio
Highest at 824.39%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Depreciation
Highest at HKD 296.47 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Grand Pharmaceutical Group Ltd.

Interest Coverage Ratio
Lowest at 1,036.74
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow
Lowest at HKD 3,224.69 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Operating Profit
Lowest at HKD 850 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin
Lowest at 13.76 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at HKD 491.98 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD 220.51 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

Net Profit
Fallen at -70.85%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS
Lowest at HKD 0.02
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Raw Material Cost
Grown by 12.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales